HOME >> BIOLOGY >> NEWS
Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils

Blacksburg, Va., May 12, 2005 Researchers from China and the United States have found evidence of lichen-like symbiosis in 600-million-year-old fossils from South China. The previous earliest evidence of lichen was 400 million years old, discovered in Scotland. The discovery also adds to the scarce fossil record of fungi and raises new questions about lichen evolution.

Xunlai Yuan, a paleontologist with the Nanjing Institute of Geology and Palaeontology; Shuhai Xiao, assistant professor of geosciences at Virginia Tech; and Thomas N. Taylor, professor of ecology and evolutionary biology at the University of Kansas, report their finding in the May 13 issue of Science ("Lichen-Like Symbiosis 600 Million Years Ago").

Yuan, Xiao, and their collaborators have been exploring the Doushantuo Formation in South China for a decade and have co-authored numerous reports of fossil discoveries, including algae and animal embryos. Taylor, a member of the National Academy of Sciences, is a paleobotanist who has reported on fossil lichens in Scotland.

Lichen is a consortium of two organisms that collaborate to survive in a harsh environment, such as exposed rock. One partner, a cyanobacterium or a photosynthetic alga, or both, are able to form food from carbon dioxide, while the other partner, a fungus, provides moisture, nutrients, and protection for the consortium.

"When and where did they first learn the tricks to form this collaboration?" Xiao asked. "The earliest lichen fossils described by Professor Taylor were from non-marine deposits about 400 million years old, when plants began to massively colonize the land. But did cyanobacteria or other algae form similar relationships with fungi in the marine environment, perhaps long before the evolution of land plants?"

Present-day examples of such relationships in the sea are abundant. Now, there is an example from ancient ocean life.

At a site where abundant algae lived in a shallow
'"/>

Contact: Susan Trulove
STrulove@vt.edu
540-231-5646
Virginia Tech
12-May-2005


Page: 1 2 3

Related biology news :

1. A private bandwidth for communication in bats: Evidence from insular horseshoe bats
2. Evidence of rapid evolution is found at the tips of chromosomes
3. Evidence human activities have shaped large-scale ecological patterns
4. National Academies advisory: April 25 Symposium on Forensic Evidence
5. Evidence for expanded color vision for some colorblind individuals
6. Evidence of waterfowl mediated gene-flow in aquatic invertebrates
7. Evidence that human brain evolution was a special event
8. Evidence that learning is consolidated during sleep
9. Evolution of symbiosis
10. Surprising symbiosis: Glassy-winged sharpshooter eats with friends
11. Mutation in a single gene switches a fungus-grass symbiosis from mutualistic to antagonistic

Post Your Comments:
(Date:5/21/2013)... the world,s largest scientific society, invites news media ... September 8-12, 2013, in Indianapolis, Ind. It will ... at area hotels. , With more than 7,100 ... from astronomy to zoology ― the meeting ... rich assortment of spot news and feature possibilities. ...
(Date:5/21/2013)... which alter the way genes function without changing ... in the blood of pregnant women during any ... depression in the weeks after giving birth, and ... , The findings of the small study involving ... journal Molecular Psychiatry . , "Postpartum depression ...
(Date:5/20/2013)... suggests that a compound abundant in the Mediterranean diet ... , By altering a very specific step in gene ... cells that die as scheduled. , One way that ... would cause them to die on a regular cycle ... cells, led by Ohio State University researchers, found that ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
(Date:5/21/2013)... May 21, 2013 According to ... ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the ... and is expected to grow at a CAGR of ... value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the ... today that they have expanded their colony counter product ... IntelliCount, InCount and ImpressCount. These affordable colony counters ... in food microbiology and pharmaceutical manufacturing. , The previously ... A bright white enclosure with jet black accents represent ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: